Steven Cohen’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARQT
Steven Cohen's ARQT Position: Q3 2026 in Review
Steven Cohen sold out of Arcutis Biotherapeutics (ARQT) in Q3 2026, closing a stake of 362,449 shares — an estimated $9.5M sold.
Steven Cohen first reported a position in ARQT in Q3 2020 and held it in 18 quarters. The position peaked at $72.3M in Q3 2022. 294 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.
- Steven Cohen reported no remaining Arcutis Biotherapeutics position as of Q3 2026 after selling out during the quarter.
- Steven Cohen sold 362,449 Arcutis Biotherapeutics shares in Q3 2026, an estimated $9.5M.
- Steven Cohen first reported a position in Arcutis Biotherapeutics in Q3 2020 and held it in 18 quarters.
- Steven Cohen's Arcutis Biotherapeutics position peaked at $72.3M in Q3 2022.
- 294 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.